Virtus ETF Advisers’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,705
| Closed | -$313K | – | 461 |
|
|
2024
Q4 | $313K | Sell |
3,705
-837
| -18% | -$77K | 0.13% | 242 |
|
|
2024
Q3 | $408K | Hold |
4,542
| – | – | 0.19% | 199 |
|
|
2024
Q2 | $366K | Sell |
4,542
-658
| -13% | -$48.7K | 0.18% | 188 |
|
|
2024
Q1 | $415K | Buy |
5,200
+748
| +17% | +$62.8K | 0.22% | 190 |
|
|
2023
Q4 | $354K | Buy |
4,452
+690
| +18% | +$46.1K | 0.22% | 184 |
|
|
2023
Q3 | $263K | Sell |
3,762
-485
| -11% | -$36.3K | 0.16% | 218 |
|
|
2023
Q2 | $305K | Buy |
4,247
+387
| +10% | +$28.5K | 0.18% | 203 |
|
|
2023
Q1 | $238K | Buy |
3,860
+65
| +2% | +$4.27K | 0.13% | 292 |
|
|
2022
Q4 | $293K | Sell |
3,795
-6,618
| -64% | -$396K | 0.15% | 279 |
|
|
2022
Q3 | $465K | Buy |
10,413
+154
| +2% | +$7.7K | 0.19% | 218 |
|
|
2022
Q2 | $393K | Buy |
10,259
+5,206
| +103% | +$165K | 0.15% | 255 |
|
|
2022
Q1 | $209K | Sell |
5,053
-297
| -6% | -$9.21K | 0.09% | 195 |
|
|
2021
Q4 | $202K | Buy |
5,350
+2,204
| +70% | +$81.1K | 0.08% | 203 |
|
|
2021
Q3 | $104K | Sell |
3,146
-167
| -5% | -$6.51K | 0.05% | 379 |
|
|
2021
Q2 | $223K | Sell |
3,313
-445
| -12% | -$26.7K | 0.09% | 265 |
|
|
2021
Q1 | $213K | Buy |
3,758
+68
| +2% | +$4.78K | 0.09% | 316 |
|
|
2020
Q4 | $301K | Sell |
3,690
-579
| -14% | -$43.3K | 0.12% | 208 |
|
|
2020
Q3 | $304K | Sell |
4,269
-570
| -12% | -$44.4K | 0.16% | 217 |
|
|
2020
Q2 | $398K | Sell |
4,839
-2,849
| -37% | -$219K | 0.19% | 195 |
|
|
2020
Q1 | $452K | Sell |
7,688
-1,113
| -13% | -$90.7K | 0.19% | 181 |
|
|
2019
Q4 | $910K | Sell |
8,801
-2,275
| -21% | -$91.9K | 0.15% | 151 |
|
|
2019
Q3 | $224K | Sell |
11,076
-616
| -5% | -$15.8K | 0.05% | 227 |
|
|
2019
Q2 | $301K | Buy |
+11,692
| New | +$234K | 0.06% | 210 |
|
Other funds holding AXSM
RI
BI
FFM